Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing application for Oleogel-S10, its drug for rare and debilitating skin disease epidermolysis ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

Research into new bandaging aims to ease the agony experienced by those living with genetic skin condition Epidermolysis Bullosa (EB), commonly referred to as 'butterfly skin'. Scientists at ...

for the treatment of dystrophic epidermolysis bullosa (DEB) that was scheduled for December 6, 2024, and asked the Company to submit written responses to the remaining outstanding issues.

Hassan, who lives in Germany, has a genetic disease - junctional epidermolysis bullosa - that leaves his skin as fragile as a butterfly's wings. A piece of his skin was taken, its DNA was repaired ...

The Hollywood A-lister and Emma Fogarty, who is Ireland’s longest-surviving person battling the genetic condition ...

for the treatment of Epidermolysis Bullosa (EB) and/or Dystrophic Epidermolysis Bullosa (DEB). 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and ...

InMed has a lead drug candidate in clinical development—INM-755, a CBN-based topical dermatological cream for the treatment of epidermolysis bullosa; a second drug candidate in preclinical ...

The former Liverpool, Rangers and Scotland player fought back tears as he told the BBC that Epidermolysis bullosa was the "cruellest disease out there". He was inspired to take on the 16-hour ...

CHMP opinion now expected in 1Q 2025No Major Objections outstanding; continue to expect Germany launch in 2Q 2025PITTSBURGH, Dec. 09, 2024 ...